Sachin shared the video on Twitter and Instagram. © Screengrab/Twitter Sachin Tendulkar, former Australian speedy bowler Brett Lee And South African legend Jonty Rhodes determined to boost their Diwali celebrations with one thing candy. The cricketing veterans tasted a lot of Indian goodies with their eyes close, and due to this fact tried to …
Reported by The News Articles 9 hours ago.
Watch: Sachin Tendulkar, Brett Lee And Jonty Rhodes Bond Over "Mithai"
↧
↧
Mobile clinic to offer free medical care for veterans' service animals
The clinic, which is run by Paws of War, will offer a range of services, from wellness checks, vaccinations, and spaying or neutering, to tooth extractions, minor surgeries, and microchip identification tag implants.
Reported by Newsday 8 hours ago.
↧
Setauket-area vets plan would add more recent conflicts to old war memorials
Not far from where he told a Suffolk legislator at last May's Setauket Memorial Day parade of a gnawing problem, Jack Gozdziewski stood Thursday with fellow veterans to solemnly celebrate what they hope will be a solution.
Reported by Newsday 8 hours ago.
↧
Warren Henry Auto Group Brings Bugatti to Broward County
Warren Henry Auto Group becomes the second dealership in the state of Florida to add the Bugatti brand to their extensive luxury portfolio.
MIAMI (PRWEB) November 08, 2018
Warren Henry Auto Group, South Florida’s premier luxury auto group, is pleased to announce the newest addition to our family, BUGATTI BROWARD. Bugatti Broward will be located at 4645 Volunteer Rd, Davie, FL 33330.
Three pillars of excellence define the Bugatti brand; Art, Form and Technique. Continuing the legacy of the founding Bugatti family, every vehicle is a work of art representing an incomparable and fascinating masterpiece. With a long history of racing successes, Bugatti has become a legend in the automotive world. The brand’s DNA represents an impressive fusion of power and beauty.
Continuing a legacy of premium, luxury vehicles, Warren Henry Auto Group holds an extensive portfolio which is naturally inviting to the Bugatti brand. Home of brands such as Jaguar, Land Rover and Lamborghini, the auto group has a successful history of delivering a premium, luxury experience to South Florida. “We are extremely excited about the addition of Bugatti Broward to the Warren Henry family. The Bugatti brand represents a rich history in automotive achievement and presents an excellent opportunity for South Florida driving enthusiasts,” said Larry Zinn, Organizational General Manager for Warren Henry Auto Group. It’s been a great year for the auto group with recognition as South Florida Business Journal’s “2018 Fast 50” which recognizes the region’s 50 fastest-growing private companies, with three of their dealerships – Land Rover North Dade; Land Rover South Dade and Warren Henry Infiniti – named to the J.D. Power “Dealers of Excellent List” and had five of its dealerships having just been recognized as Automotive News’ “100 Best Dealerships to Work For.”
Bugatti Broward will be showcasing the Bugatti Chiron at this year’s inaugural Exotics on Las Olas event this Sunday, November 11 in Fort Lauderdale from 11am to 2pm. The event showcases some of the rarest, most striking automobiles in South Florida. Part of the proceeds from the showcase will go towards the Wounded Veteran’s Relief Fund, a non-profit organization that caters to veterans injured in military action following the attacks of September 11, 2001.
About Warren Henry Auto Group
Over four decades and three generations, Warren Henry Auto Group has built an esteemed reputation through its commitment to service excellence, superior quality, Advantage products and unwavering community support. Warren Henry Auto Group includes a diverse portfolio of vehicle brands including Jaguar, Land Rover, Infiniti, Audi, Lamborghini, Koenigsegg, Toyota, Ford, Chrysler, Dodge, Jeep and RAM. Warren Henry Auto Group’s corporate office is located at 20860 NW 2nd Avenue (Hwy. 441) in Miami, and will be relocating to North Miami’s SoLe Mia development in early 2019. For more information, call 888-856-3113 or visit http://www.warrenhenryauto.com.
About Bugatti
Bugatti Automobiles S.A.S. is the manufacturer of the ultimate production super sports car, the Chiron. With a power output of 1,500 HP, unprecedented for production vehicles, an exceptionally high torque value of 1,180 ft-lb between 2,000 and 6,000 rpm and a wide variety of technical innovations, the Chiron sets new standards in every respect. The Chiron is not only designed for maximum speed but also meets the highest possible demands in terms of luxury, comfort, everyday drivability and durability. The Chiron combines the best in all these areas which makes it the world’s most complete super sports car and a unique concept.
Since it was established in 1909, Bugatti has had its headquarters at Molsheim, Alsace, where 450 Veyrons were hand-crafted from 2005 to 2015. The production of the Chiron started in the autumn of 2016. With 70 cars built and delivered to customers all over the world, Bugatti successfully closed the Chiron’s first full year of production in 2017.
The French luxury brand, which has been part of the Volkswagen Group since 1998, employs about 300 people. With dealers and service partners in 17 countries in Europe, North America, the Arabian Peninsula and Asia-Pacific, Bugatti is a global player.
##### Reported by PRWeb 8 hours ago.
MIAMI (PRWEB) November 08, 2018
Warren Henry Auto Group, South Florida’s premier luxury auto group, is pleased to announce the newest addition to our family, BUGATTI BROWARD. Bugatti Broward will be located at 4645 Volunteer Rd, Davie, FL 33330.
Three pillars of excellence define the Bugatti brand; Art, Form and Technique. Continuing the legacy of the founding Bugatti family, every vehicle is a work of art representing an incomparable and fascinating masterpiece. With a long history of racing successes, Bugatti has become a legend in the automotive world. The brand’s DNA represents an impressive fusion of power and beauty.
Continuing a legacy of premium, luxury vehicles, Warren Henry Auto Group holds an extensive portfolio which is naturally inviting to the Bugatti brand. Home of brands such as Jaguar, Land Rover and Lamborghini, the auto group has a successful history of delivering a premium, luxury experience to South Florida. “We are extremely excited about the addition of Bugatti Broward to the Warren Henry family. The Bugatti brand represents a rich history in automotive achievement and presents an excellent opportunity for South Florida driving enthusiasts,” said Larry Zinn, Organizational General Manager for Warren Henry Auto Group. It’s been a great year for the auto group with recognition as South Florida Business Journal’s “2018 Fast 50” which recognizes the region’s 50 fastest-growing private companies, with three of their dealerships – Land Rover North Dade; Land Rover South Dade and Warren Henry Infiniti – named to the J.D. Power “Dealers of Excellent List” and had five of its dealerships having just been recognized as Automotive News’ “100 Best Dealerships to Work For.”
Bugatti Broward will be showcasing the Bugatti Chiron at this year’s inaugural Exotics on Las Olas event this Sunday, November 11 in Fort Lauderdale from 11am to 2pm. The event showcases some of the rarest, most striking automobiles in South Florida. Part of the proceeds from the showcase will go towards the Wounded Veteran’s Relief Fund, a non-profit organization that caters to veterans injured in military action following the attacks of September 11, 2001.
About Warren Henry Auto Group
Over four decades and three generations, Warren Henry Auto Group has built an esteemed reputation through its commitment to service excellence, superior quality, Advantage products and unwavering community support. Warren Henry Auto Group includes a diverse portfolio of vehicle brands including Jaguar, Land Rover, Infiniti, Audi, Lamborghini, Koenigsegg, Toyota, Ford, Chrysler, Dodge, Jeep and RAM. Warren Henry Auto Group’s corporate office is located at 20860 NW 2nd Avenue (Hwy. 441) in Miami, and will be relocating to North Miami’s SoLe Mia development in early 2019. For more information, call 888-856-3113 or visit http://www.warrenhenryauto.com.
About Bugatti
Bugatti Automobiles S.A.S. is the manufacturer of the ultimate production super sports car, the Chiron. With a power output of 1,500 HP, unprecedented for production vehicles, an exceptionally high torque value of 1,180 ft-lb between 2,000 and 6,000 rpm and a wide variety of technical innovations, the Chiron sets new standards in every respect. The Chiron is not only designed for maximum speed but also meets the highest possible demands in terms of luxury, comfort, everyday drivability and durability. The Chiron combines the best in all these areas which makes it the world’s most complete super sports car and a unique concept.
Since it was established in 1909, Bugatti has had its headquarters at Molsheim, Alsace, where 450 Veyrons were hand-crafted from 2005 to 2015. The production of the Chiron started in the autumn of 2016. With 70 cars built and delivered to customers all over the world, Bugatti successfully closed the Chiron’s first full year of production in 2017.
The French luxury brand, which has been part of the Volkswagen Group since 1998, employs about 300 people. With dealers and service partners in 17 countries in Europe, North America, the Arabian Peninsula and Asia-Pacific, Bugatti is a global player.
##### Reported by PRWeb 8 hours ago.
↧
Influx of military veterans heads to Washington
Washington (AFP) Nov 7, 2018
Among the winners in America's bitter midterm elections were dozens of military veterans, whose "mission first" mindset could help in a deeply divided Congress where the notion of bipartisanship has all but disappeared. At least 16 "freshmen" veterans were elected for the first time to serve in the House of Representatives, the largest influx of new vets since 2010. Final tallies were st Reported by Terra Daily 7 hours ago.
Among the winners in America's bitter midterm elections were dozens of military veterans, whose "mission first" mindset could help in a deeply divided Congress where the notion of bipartisanship has all but disappeared. At least 16 "freshmen" veterans were elected for the first time to serve in the House of Representatives, the largest influx of new vets since 2010. Final tallies were st Reported by Terra Daily 7 hours ago.
↧
↧
Remembrance Day one hundred years on
Australia's veterans and political leaders will gather around the country and the world on November 11 to mark 100 years since the end of the Great War.
Reported by SBS 6 hours ago.
↧
Free bus rides for veterans this Sunday
THE CITY’S buses are offering free travel for veterans and serving members of the Armed Forces this Remembrance Sunday.
Reported by The Argus 4 hours ago.
↧
Andrews pledges $1.5m to improve mental healthcare for veterans
Labor has promised increased access to veteran mental health care if re-elected on November 24.
Reported by Brisbane Times 3 hours ago.
↧
BJP's two veterans denied tickets in MP Assembly polls
Reported by newKerala.com 18 minutes ago.
↧
↧
“The Living Legacy of the First World War”: Carnegie Council Marks the 100th Anniversary of Armistice Day
On the 100th anniversary of Armistice Day, Carnegie Council’s "The Living Legacy of the First World War" project joins other centennial initiatives that help rising generations to understand the weight and gravity of this moment in global history and the War's lasting imprint on the present.
(PRWEB) November 09, 2018
Sunday, November 11, 2018 is the 100th anniversary of the armistice that ended World War I. With the passing of the last veterans of the Great War, active public remembrance is essential. Carnegie Council’s "The Living Legacy of the First World War" project joins other centennial initiatives that help rising generations to understand the weight and gravity of this moment in global history.
Launched in the summer of 2017, the goal of “The Living Legacy” project is to publish original research on the war, its long-term impacts on societies around the world, particularly the United States, and its lasting imprint on the present.
This fellowship program is led by Senior Fellow Col. Reed Bonadonna (ret.), Nine research fellows were selected: see below. The project was made possible by a grant from the Richard Lounsbery Foundation.
In September 2018, Bonadonna and four of the fellows attended the Carnegie Peacebuilding Conversations, a three-day program at the Peace Palace in The Hague, presented by Carnegie institutions worldwide and other partners. They were the panelists for a session titled “Education for Peace: The Living Legacy of WWI. “ Access the transcript and video here: https://www.carnegiecouncil.org/studio/multimedia/20180925-education-for-peace-living-legacy-first-world-war.
As part of the city’s commemoration, of the World War I Centennial, the five other fellows will travel to New York and present their work at a Carnegie Council luncheon on November 13 at 12 noon EST. Watch the live webcast here: https://www.carnegiecouncil.org/live.
Here are the nine selected fellows and their research themes. For interviews with all the fellows about their work, go to: https://www.carnegiecouncil.org/programs/WWI/resources.
Katherine Akey, artist, Washington, DC: “Collective Memory and the Hidden Photographic Narratives of World War I”
Mary Barton, Office of the Secretary of Defense (OSD) Historical Office: “European and American Counterterrorism Strategies in the Aftermath of World War I”
Christopher Capozzola, Massachusetts Institute of Technology (MIT): “Merchants of Death? The politics of Defense Contracting, Then and Now”
Philip Caruso, Harvard University: “Airpower During World War I: Transforming International Law”
Zach Dorfman, investigative journalist and Carnegie Council Senior Fellow: “Chemical Weapons from the Great War to Syria and Beyond”
Tanisha Fazal, University of Minnesota: “The Politics and Medicine of Treating Post-Traumatic Stress Since World War I”
Richard Millett, University of Missouri-St. Louis: “The United States, the Western Hemisphere, and World War I: Forgotten Aspects”
Seiko Mimaki, Takasaki City University of Economics, Japan: “World War I as a Key Moment in the History of Humanitarianism: Jane Addams and Her Cosmopolitan Ethics”
Charles Sorrie, Trent University, Canada: “The Legacy of American Press Censorship During the First World War”
ABOUT CARNEGIE COUNCIL
Founded by Andrew Carnegie in 1914, Carnegie Council for Ethics in International Affairs is an educational, nonprofit, nonpartisan organization that produces lectures, publications, and multimedia materials on the ethical challenges of living in a globalized world. Go to https://www.carnegiecouncil.org/. Reported by PRWeb 2 hours ago.
(PRWEB) November 09, 2018
Sunday, November 11, 2018 is the 100th anniversary of the armistice that ended World War I. With the passing of the last veterans of the Great War, active public remembrance is essential. Carnegie Council’s "The Living Legacy of the First World War" project joins other centennial initiatives that help rising generations to understand the weight and gravity of this moment in global history.
Launched in the summer of 2017, the goal of “The Living Legacy” project is to publish original research on the war, its long-term impacts on societies around the world, particularly the United States, and its lasting imprint on the present.
This fellowship program is led by Senior Fellow Col. Reed Bonadonna (ret.), Nine research fellows were selected: see below. The project was made possible by a grant from the Richard Lounsbery Foundation.
In September 2018, Bonadonna and four of the fellows attended the Carnegie Peacebuilding Conversations, a three-day program at the Peace Palace in The Hague, presented by Carnegie institutions worldwide and other partners. They were the panelists for a session titled “Education for Peace: The Living Legacy of WWI. “ Access the transcript and video here: https://www.carnegiecouncil.org/studio/multimedia/20180925-education-for-peace-living-legacy-first-world-war.
As part of the city’s commemoration, of the World War I Centennial, the five other fellows will travel to New York and present their work at a Carnegie Council luncheon on November 13 at 12 noon EST. Watch the live webcast here: https://www.carnegiecouncil.org/live.
Here are the nine selected fellows and their research themes. For interviews with all the fellows about their work, go to: https://www.carnegiecouncil.org/programs/WWI/resources.
Katherine Akey, artist, Washington, DC: “Collective Memory and the Hidden Photographic Narratives of World War I”
Mary Barton, Office of the Secretary of Defense (OSD) Historical Office: “European and American Counterterrorism Strategies in the Aftermath of World War I”
Christopher Capozzola, Massachusetts Institute of Technology (MIT): “Merchants of Death? The politics of Defense Contracting, Then and Now”
Philip Caruso, Harvard University: “Airpower During World War I: Transforming International Law”
Zach Dorfman, investigative journalist and Carnegie Council Senior Fellow: “Chemical Weapons from the Great War to Syria and Beyond”
Tanisha Fazal, University of Minnesota: “The Politics and Medicine of Treating Post-Traumatic Stress Since World War I”
Richard Millett, University of Missouri-St. Louis: “The United States, the Western Hemisphere, and World War I: Forgotten Aspects”
Seiko Mimaki, Takasaki City University of Economics, Japan: “World War I as a Key Moment in the History of Humanitarianism: Jane Addams and Her Cosmopolitan Ethics”
Charles Sorrie, Trent University, Canada: “The Legacy of American Press Censorship During the First World War”
ABOUT CARNEGIE COUNCIL
Founded by Andrew Carnegie in 1914, Carnegie Council for Ethics in International Affairs is an educational, nonprofit, nonpartisan organization that produces lectures, publications, and multimedia materials on the ethical challenges of living in a globalized world. Go to https://www.carnegiecouncil.org/. Reported by PRWeb 2 hours ago.
↧
Veterans are a building block of the middle class
Reported by DallasNews 2 hours ago.
↧
Thousand Oaks shooting: Victims of bar attack
The sufferers of the mass taking pictures in Thousand Oaks, California, come with military veterans, scholars and a police officer. The households of the lifeless have paid tribute hardworking, loving and full of life characters. Here’s what we find out about those that have been killed. Sergeant Ron Helus, 54 Symbol: Sergeant Ron Helus was …
Reported by The News Articles 2 hours ago.
↧
United States: Massachusetts Veterans Entitled To Time Off On Veterans Day - McLane Middleton, Professional Association
In July 2018, Governor Charlie Baker signed the BRAVE Act, a wide-ranging piece of legislation including a number of provisions aimed at increasing the support and services available to veterans
Reported by Mondaq 1 hour ago.
↧
↧
Life as a World War One veteran in 'war zone' Ireland
The chaos of revolutionary Ireland posed big challenges in caring for disabled World War One veterans.
Reported by BBC News 50 minutes ago.
↧
GovX Community Raises $24,000+ for Disaster Response Organization Team Rubicon
Team Rubicon unites military veterans and first responders to rapidly deploy emergency response teams following natural disaster or humanitarian crises.
SAN DIEGO (PRWEB) November 09, 2018
A fundraising effort organized by GovX, the online shopping site exclusively for current and former military and first responders, raised over $24,000 for the disaster relief organization Team Rubicon.
The CrowdRise fundraiser lasted for three months, and drew donations from members of the GovX community - people with service-related backgrounds in every branch of the US Armed Forces, law enforcement, firefighting, and emergency responder departments across the country. One randomly chosen member of the GovX community who donated at least $10 to Team Rubicon won a $5,000 GovX shopping spree.
"Team Rubicon is thankful for the support from GovX and the GovX community," said Art delaCruz, COO at Team Rubicon. "This generous donation will put more volunteers in the field and more homeowners one step closer to normalcy. It's companies like GovX that allow Team Rubicon’s impact to grow and positively affect more natural disaster survivors."
As a veteran service organization, Team Rubicon deploys response teams comprised mostly of individuals with military and first responder backgrounds. The organization seeks to provide veterans and former uniformed professionals with the purpose, community, and identity they gained during their time in active service. By joining a new mission, many veterans regain a sense of belonging through their commitment to service and passion for helping others.
Founded by US Marine Corps veterans William McNulty and Jacob Wood in 2010, Team Rubicon has over 90,000 volunteer members, or "Greyshirts" who stand ready to deploy wherever natural catastrophes and humanitarian crises occur. Since 2010, they have deployed on over 300 responses, including recently to the Carolinas following the devastating impact of Hurricane Florence in September. Team Rubicon is currently operating an Emergency Medical Team in the Northern Mariana Islands assisting survivors of Super Typhoon Yutu.
"We knew that the GovX community would enthusiastically support this incredible veteran-powered response team," said Alan Cole, GovX CEO. "But our members' compassion for veterans and their fellow Americans exceeded our expectations. It was truly amazing to see our community step up in the way that they did to support Team Rubicon."
The fundraiser was the inaugural effort of GovX Gives Back, a new phase of GovX's support for veterans and uniformed professionals. The GovX community has a four-year history of supporting military and first responder nonprofits. With the support of members, GovX has donated over $200,000 to organizations such as the National Law Enforcement Officer's Memorial Fund, National Fallen Firefighter Foundation, Iraq and Afghanistan Veterans of America, and many others.
GovX's current fundraiser benefits Homes For Our Troops, the nonprofit that builds specially adapted custom homes and donates them mortgage free to severely injured post-9/11 veterans. Interested GovX members can donate here for a chance to win a trip to Las Vegas.
ABOUT GOVX
GovX.com is for the men and women who protect our country and communities. The members-only eCommerce site offers thousands of products from hundreds of premium brands at exclusive, below-retail pricing. Eligible members include active and veteran U.S. military, firefighters, law enforcement officers and federal agents. Membership is free and more information can be found at http://www.govx.com.
ABOUT TEAM RUBICON
Team Rubicon unites the skills and experiences of military veterans with first responders to rapidly deploy emergency response teams. Team Rubicon is a nonprofit organization offering veterans a chance to continue their service by helping those affected by disasters, and also themselves. Programs and services are made possible by the support of individual donors, corporate partners, and the dedication of volunteers across the country. To join or support Team Rubicon’s mission, visit http://www.teamrubiconusa.org. Reported by PRWeb 52 minutes ago.
SAN DIEGO (PRWEB) November 09, 2018
A fundraising effort organized by GovX, the online shopping site exclusively for current and former military and first responders, raised over $24,000 for the disaster relief organization Team Rubicon.
The CrowdRise fundraiser lasted for three months, and drew donations from members of the GovX community - people with service-related backgrounds in every branch of the US Armed Forces, law enforcement, firefighting, and emergency responder departments across the country. One randomly chosen member of the GovX community who donated at least $10 to Team Rubicon won a $5,000 GovX shopping spree.
"Team Rubicon is thankful for the support from GovX and the GovX community," said Art delaCruz, COO at Team Rubicon. "This generous donation will put more volunteers in the field and more homeowners one step closer to normalcy. It's companies like GovX that allow Team Rubicon’s impact to grow and positively affect more natural disaster survivors."
As a veteran service organization, Team Rubicon deploys response teams comprised mostly of individuals with military and first responder backgrounds. The organization seeks to provide veterans and former uniformed professionals with the purpose, community, and identity they gained during their time in active service. By joining a new mission, many veterans regain a sense of belonging through their commitment to service and passion for helping others.
Founded by US Marine Corps veterans William McNulty and Jacob Wood in 2010, Team Rubicon has over 90,000 volunteer members, or "Greyshirts" who stand ready to deploy wherever natural catastrophes and humanitarian crises occur. Since 2010, they have deployed on over 300 responses, including recently to the Carolinas following the devastating impact of Hurricane Florence in September. Team Rubicon is currently operating an Emergency Medical Team in the Northern Mariana Islands assisting survivors of Super Typhoon Yutu.
"We knew that the GovX community would enthusiastically support this incredible veteran-powered response team," said Alan Cole, GovX CEO. "But our members' compassion for veterans and their fellow Americans exceeded our expectations. It was truly amazing to see our community step up in the way that they did to support Team Rubicon."
The fundraiser was the inaugural effort of GovX Gives Back, a new phase of GovX's support for veterans and uniformed professionals. The GovX community has a four-year history of supporting military and first responder nonprofits. With the support of members, GovX has donated over $200,000 to organizations such as the National Law Enforcement Officer's Memorial Fund, National Fallen Firefighter Foundation, Iraq and Afghanistan Veterans of America, and many others.
GovX's current fundraiser benefits Homes For Our Troops, the nonprofit that builds specially adapted custom homes and donates them mortgage free to severely injured post-9/11 veterans. Interested GovX members can donate here for a chance to win a trip to Las Vegas.
ABOUT GOVX
GovX.com is for the men and women who protect our country and communities. The members-only eCommerce site offers thousands of products from hundreds of premium brands at exclusive, below-retail pricing. Eligible members include active and veteran U.S. military, firefighters, law enforcement officers and federal agents. Membership is free and more information can be found at http://www.govx.com.
ABOUT TEAM RUBICON
Team Rubicon unites the skills and experiences of military veterans with first responders to rapidly deploy emergency response teams. Team Rubicon is a nonprofit organization offering veterans a chance to continue their service by helping those affected by disasters, and also themselves. Programs and services are made possible by the support of individual donors, corporate partners, and the dedication of volunteers across the country. To join or support Team Rubicon’s mission, visit http://www.teamrubiconusa.org. Reported by PRWeb 52 minutes ago.
↧
AC Immune Shares Insights from Key Opinion Leader Meeting on Abeta Oligomers in Alzheimer's Disease (AD) and Other Misfolded Proteins in AD and Neurodegenerative Diseases
· *Increasing evidence points to Abeta oligomers as the toxic species in AD, and likely linked to Tau pathology and neuroinflammation.*
· *Immunotherapies and small molecule anti-Tau therapeutics hold much promise in treating AD and neurodegenerative orphan indications.*
· *Additional misfolded proteins, alpha-synuclein and TDP-43 exist alongside Beta-amyloid and Tau as concomitant pathologies, suggesting precision medicine approaches are required for treating AD and other neurodegenerative diseases. *
*Lausanne, Switzerland, November 9, 2018* - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, shared top level insights from its Key Opinion Leader (KOL) luncheon meeting on Abeta oligomers and concomitant proteinopathies in AD and other neurodegenerative diseases, which took place on November 5, 2018, in New York City.
The meeting featured presentations by Professor Michael W. Weiner, University of California San Francisco School of Medicine and Professor John Q. Trojanowski, Perelman School of Medicine, University of Pennsylvania.
Professor Weiner reviewed current understanding of the amyloid hypothesis of AD, emphasizing the key role Abeta oligomers as the most toxic species in the amyloid cascade, and which produce various downstream effects possibly involved in tau pathology and neuroinflammation. In regard to tau, Professor Weiner highlighted the excitement around antibody, vaccine and small molecule anti-tau therapeutics currently in clinical trials and development. Finally Professor Weiner explained the importance of diagnostics for early intervention in AD, and reviewed progress in brain PET imaging as well as molecular biomarkers in brain fluid and blood.
Professor Weiner remarked: "Alzheimer's Disease can be thought of as an amyloid induced tauopathy, and therefore therapeutics targeting amyloid and tau hold much promise in finding a cure for this devastating disease. Imaging and biomarker diagnostics, particularly blood tests, will facilitate early treatment and improved clinical outcomes.''
Professor Trojanowski highlighted the existence of concomitant pathologies in a wide range of neurodegenerative diseases, emphasizing the importance of alpha-synuclein and TDP-43, in addition to Beta-amyloid and tau. These discoveries point to the future importance of precision medicine, involving therapeutics targeting the pathological proteins relevant to an individual patients and stage of disease.
Professor Trojanowski commented: "It is becoming clearer that clinical trial participants may be better defined by their various proteinopathies and that patient sub-classification may lead to improved clinical outcomes. The high prevalence of co-pathologies in neurodegenerative diseases, as well variation between individuals, indicates that diagnostics and combination therapy may be the ultimate requirement."
Following the KOL presentations, Prof. Andrea Pfeifer, CEO of AC Immune, gave an overview of the Company's pipeline and strategy to be a leader in precision medicine in neurodegenerative diseases. The Company has nine products in various stages of clinical development and a sustainable pipeline of pre-clinical assets addressing key targets in AD and neurodegenerative diseases.
Professor Andrea Pfeifer commented: "We're starting to see a clearer and more important need for precision medicine with the prevalence of co-pathology in AD, Parkinson's and other neurodegenerative diseases. Our current therapeutic and diagnostic pipeline forms the basis of our forward strategy to become a leader in precision medicine as applied to AD and other neurodegenerative diseases."
A replay of the event is available on the Investor page of AC Immune's website.
*KOL Biographies*
*Michael W. Weiner M.D.*
Professor, Department of Radiology
University of California San Francisco School of Medicine
Dr. Weiner is Professor in Residence in Radiology and Biomedical Imaging, Medicine, Psychiatry, and Neurology at the University of California, San Francisco. He is Principle Investigator of the Alzheimer's Disease Neuroimaging Initiative, which is the largest observational study in the world concerning Alzheimer's Disease. He is the former Director of the Center for Imaging of Neurodegenerative Diseases (CIND) at the San Francisco Veterans Affairs Medical Center. During the past 25 years he has worked to develop and optimized the use of MRI, PET, and blood based biomarker methods to diagnose Alzheimer's disease and other neurodegenerative disorders. Dr. Weiner's research also focuses on monitoring effects of treatment to slow progressions in Alzheimer's disease, and detecting Alzheimer's disease early in patients who are not demented, but risk subsequent development of dementia.
*John Q. Trojanowski M.D., Ph.D.*
Co-Director Center for Neurodegenerative Research
Perelman School of Medicine
University of Pennsylvania
Dr. Trojanowski obtained his MD/PhD in 1976 from Tufts University, did his internal medicine internship at Mt. Auburn Hospital, his pathology and neuropathology at Massachusetts General Hospital and the University of Pennsylvania Perelman School of Medicine where he joined the faculty in 1981. He is Professor of Pathology and Laboratory Medicine, Director of the NIA Alzheimer's Disease Center, the National Institute of Neurological Disorders (NINDS) Morris K. Udall Parkinson's Disease Center, and the Institute on Aging. His research focuses on Alzheimer's (AD) and Parkinson's (PD) disease, amyotrophic lateral sclerosis (ALS), frontotemporal degeneration (FTD) which led to the discovery of the major disease proteins in these disorders.
*About AC Immune *
AC Immune is a clinical-stage Swiss-based biopharmaceutical company, listed on NASDAQ, which aims to become a global leader in precision medicine for neurodegenerative diseases. The Company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. AC Immune's two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline features nine therapeutic and three diagnostic product candidates - with five product candidates currently in clinical trials. The most advanced of these is crenezumab, a humanized anti-amyloid-ß monoclonal IgG4 antibody that targets monomeric and aggregated forms of amyloid-ß, with highest affinity for neurotoxic oligomers. Crenezumab is currently in two Phase 3 clinical studies for AD, under a global program conducted by the collaboration partner Roche/Genentech. Other collaborations include Biogen, Janssen Pharmaceuticals, Nestlé Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.
*Forward looking statements *
This press release contains statements that constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are statements other than historical fact and may include statements that address future operating, financial or business performance or AC Immune's strategies or expectations. In some cases, you can identify these statements by forward-looking words such as "may,""might,""will,""should,""expects,""plans,""anticipates,""believes,""estimates,""predicts,""projects,""potential,""outlook" or "continue," and other comparable terminology. Forward-looking statements are based on management's current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements. These risks and uncertainties include those described under the captions "Item 3. Key Information-Risk Factors" and "Item 5. Operating and Financial Review and Prospects" in AC Immune's Annual Report on Form 20-F and other filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and AC Immune does not undertake any obligation to update them in light of new information, future developments or otherwise, except as may be required under applicable law. All forward-looking statements are qualified in their entirety by this cautionary statement.
*For further information, please contact:*
*In Europe*
Beatrix Benz
AC Immune Corporate Communications
Phone: +41 21 345 91 34
E-mail: beatrix.benz@acimmune.com *In the US*
Lisa Sher
AC Immune Investor Relations
Phone: +1 970 987 26 54
E-mail: lisa.sher@acimmune.com
Nick Miles/Toomas Kull
Cabinet Privé de Conseils s.a.
Phone: +41 22 552 46 46
E-mail: miles@cpc-pr.com
kull@cpc-pr.com Ted Agne
The Communications Strategy Group Inc.
Phone: +1 781 631 3117
E-mail: edagne@comstratgroup.com
*Attachment*
· English.pdf Reported by GlobeNewswire 49 minutes ago.
· *Immunotherapies and small molecule anti-Tau therapeutics hold much promise in treating AD and neurodegenerative orphan indications.*
· *Additional misfolded proteins, alpha-synuclein and TDP-43 exist alongside Beta-amyloid and Tau as concomitant pathologies, suggesting precision medicine approaches are required for treating AD and other neurodegenerative diseases. *
*Lausanne, Switzerland, November 9, 2018* - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, shared top level insights from its Key Opinion Leader (KOL) luncheon meeting on Abeta oligomers and concomitant proteinopathies in AD and other neurodegenerative diseases, which took place on November 5, 2018, in New York City.
The meeting featured presentations by Professor Michael W. Weiner, University of California San Francisco School of Medicine and Professor John Q. Trojanowski, Perelman School of Medicine, University of Pennsylvania.
Professor Weiner reviewed current understanding of the amyloid hypothesis of AD, emphasizing the key role Abeta oligomers as the most toxic species in the amyloid cascade, and which produce various downstream effects possibly involved in tau pathology and neuroinflammation. In regard to tau, Professor Weiner highlighted the excitement around antibody, vaccine and small molecule anti-tau therapeutics currently in clinical trials and development. Finally Professor Weiner explained the importance of diagnostics for early intervention in AD, and reviewed progress in brain PET imaging as well as molecular biomarkers in brain fluid and blood.
Professor Weiner remarked: "Alzheimer's Disease can be thought of as an amyloid induced tauopathy, and therefore therapeutics targeting amyloid and tau hold much promise in finding a cure for this devastating disease. Imaging and biomarker diagnostics, particularly blood tests, will facilitate early treatment and improved clinical outcomes.''
Professor Trojanowski highlighted the existence of concomitant pathologies in a wide range of neurodegenerative diseases, emphasizing the importance of alpha-synuclein and TDP-43, in addition to Beta-amyloid and tau. These discoveries point to the future importance of precision medicine, involving therapeutics targeting the pathological proteins relevant to an individual patients and stage of disease.
Professor Trojanowski commented: "It is becoming clearer that clinical trial participants may be better defined by their various proteinopathies and that patient sub-classification may lead to improved clinical outcomes. The high prevalence of co-pathologies in neurodegenerative diseases, as well variation between individuals, indicates that diagnostics and combination therapy may be the ultimate requirement."
Following the KOL presentations, Prof. Andrea Pfeifer, CEO of AC Immune, gave an overview of the Company's pipeline and strategy to be a leader in precision medicine in neurodegenerative diseases. The Company has nine products in various stages of clinical development and a sustainable pipeline of pre-clinical assets addressing key targets in AD and neurodegenerative diseases.
Professor Andrea Pfeifer commented: "We're starting to see a clearer and more important need for precision medicine with the prevalence of co-pathology in AD, Parkinson's and other neurodegenerative diseases. Our current therapeutic and diagnostic pipeline forms the basis of our forward strategy to become a leader in precision medicine as applied to AD and other neurodegenerative diseases."
A replay of the event is available on the Investor page of AC Immune's website.
*KOL Biographies*
*Michael W. Weiner M.D.*
Professor, Department of Radiology
University of California San Francisco School of Medicine
Dr. Weiner is Professor in Residence in Radiology and Biomedical Imaging, Medicine, Psychiatry, and Neurology at the University of California, San Francisco. He is Principle Investigator of the Alzheimer's Disease Neuroimaging Initiative, which is the largest observational study in the world concerning Alzheimer's Disease. He is the former Director of the Center for Imaging of Neurodegenerative Diseases (CIND) at the San Francisco Veterans Affairs Medical Center. During the past 25 years he has worked to develop and optimized the use of MRI, PET, and blood based biomarker methods to diagnose Alzheimer's disease and other neurodegenerative disorders. Dr. Weiner's research also focuses on monitoring effects of treatment to slow progressions in Alzheimer's disease, and detecting Alzheimer's disease early in patients who are not demented, but risk subsequent development of dementia.
*John Q. Trojanowski M.D., Ph.D.*
Co-Director Center for Neurodegenerative Research
Perelman School of Medicine
University of Pennsylvania
Dr. Trojanowski obtained his MD/PhD in 1976 from Tufts University, did his internal medicine internship at Mt. Auburn Hospital, his pathology and neuropathology at Massachusetts General Hospital and the University of Pennsylvania Perelman School of Medicine where he joined the faculty in 1981. He is Professor of Pathology and Laboratory Medicine, Director of the NIA Alzheimer's Disease Center, the National Institute of Neurological Disorders (NINDS) Morris K. Udall Parkinson's Disease Center, and the Institute on Aging. His research focuses on Alzheimer's (AD) and Parkinson's (PD) disease, amyotrophic lateral sclerosis (ALS), frontotemporal degeneration (FTD) which led to the discovery of the major disease proteins in these disorders.
*About AC Immune *
AC Immune is a clinical-stage Swiss-based biopharmaceutical company, listed on NASDAQ, which aims to become a global leader in precision medicine for neurodegenerative diseases. The Company designs, discovers and develops therapeutic as well as diagnostic products intended to prevent and modify diseases caused by misfolding proteins. AC Immune's two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline features nine therapeutic and three diagnostic product candidates - with five product candidates currently in clinical trials. The most advanced of these is crenezumab, a humanized anti-amyloid-ß monoclonal IgG4 antibody that targets monomeric and aggregated forms of amyloid-ß, with highest affinity for neurotoxic oligomers. Crenezumab is currently in two Phase 3 clinical studies for AD, under a global program conducted by the collaboration partner Roche/Genentech. Other collaborations include Biogen, Janssen Pharmaceuticals, Nestlé Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.
*Forward looking statements *
This press release contains statements that constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are statements other than historical fact and may include statements that address future operating, financial or business performance or AC Immune's strategies or expectations. In some cases, you can identify these statements by forward-looking words such as "may,""might,""will,""should,""expects,""plans,""anticipates,""believes,""estimates,""predicts,""projects,""potential,""outlook" or "continue," and other comparable terminology. Forward-looking statements are based on management's current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements. These risks and uncertainties include those described under the captions "Item 3. Key Information-Risk Factors" and "Item 5. Operating and Financial Review and Prospects" in AC Immune's Annual Report on Form 20-F and other filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and AC Immune does not undertake any obligation to update them in light of new information, future developments or otherwise, except as may be required under applicable law. All forward-looking statements are qualified in their entirety by this cautionary statement.
*For further information, please contact:*
*In Europe*
Beatrix Benz
AC Immune Corporate Communications
Phone: +41 21 345 91 34
E-mail: beatrix.benz@acimmune.com *In the US*
Lisa Sher
AC Immune Investor Relations
Phone: +1 970 987 26 54
E-mail: lisa.sher@acimmune.com
Nick Miles/Toomas Kull
Cabinet Privé de Conseils s.a.
Phone: +41 22 552 46 46
E-mail: miles@cpc-pr.com
kull@cpc-pr.com Ted Agne
The Communications Strategy Group Inc.
Phone: +1 781 631 3117
E-mail: edagne@comstratgroup.com
*Attachment*
· English.pdf Reported by GlobeNewswire 49 minutes ago.
↧
Chicago Realtor John Lyons Helps Local Hospital’s NICU via Donations
Realtor John Lyons, of Baird and Warner, pledges to donate $200 per transaction to the NICU at Ann & Robert H. Lurie Children’s Hospital of Chicago.
CHICAGO (PRWEB) November 09, 2018
Realtor John Lyons, of Baird and Warner, pledges to donate $200 per transaction to the NICU at Ann & Robert H. Lurie Children’s Hospital of Chicago.
“I expect to close 10 more transactions before the end of the year, and next year I expect to close 40 deals,” said Lyons, who has earned the Outstanding Sales Achievement award from the Chicago Association of Realtors for the past three years.
The Ann & Robert H. Lurie Children’s Hospital of Chicago NICU neonatology team provides the highest level of care to the most critically ill newborns in the region, as well as superior pediatric care in a setting that offers the latest benefits and innovations in medical technology, research and family-friendly design. It is the largest pediatric provider in the region, with a 130-year legacy of excellence.
This marks the first year Lyons is working with the foundation. His daughter was in its NICU right after she was born and Lyons realized what an outstanding organization it was. “I think it is an amazing place and it should be something that’s cherished. We really need people to step up to be able to help families that need care and also help the hospital continue to provide the level of care that they do,” noted Lyons.
To donate directly to the Ann & Robert H. Lurie Children’s Hospital of Chicago, please visit https://www.luriechildrens.org/en/ways-to-help/.
In addition to the Ann & Robert H. Lurie Children’s Hospital of Chicago, Lyons has supported Home For Our Troops. The organization builds and donates custom-designed homes for veterans.
About John Lyons, Baird and Warner
John Lyons is a recipient of the Baird & Warner Founders’ Club award and the Baird & Warner Lincoln Park Best Dressed Agent award, which he earned in 2016. He works within a variety of Chicago neighborhoods, and typically services first-time buyers and sellers aiming to move out of state or into the suburbs. For more information, please call (773) 558-7133, or visit http://www.johnlyons.bairdwarner.com.
For media inquiries, please call the NALA at 805.650.6121, ext. 361. Reported by PRWeb 37 minutes ago.
CHICAGO (PRWEB) November 09, 2018
Realtor John Lyons, of Baird and Warner, pledges to donate $200 per transaction to the NICU at Ann & Robert H. Lurie Children’s Hospital of Chicago.
“I expect to close 10 more transactions before the end of the year, and next year I expect to close 40 deals,” said Lyons, who has earned the Outstanding Sales Achievement award from the Chicago Association of Realtors for the past three years.
The Ann & Robert H. Lurie Children’s Hospital of Chicago NICU neonatology team provides the highest level of care to the most critically ill newborns in the region, as well as superior pediatric care in a setting that offers the latest benefits and innovations in medical technology, research and family-friendly design. It is the largest pediatric provider in the region, with a 130-year legacy of excellence.
This marks the first year Lyons is working with the foundation. His daughter was in its NICU right after she was born and Lyons realized what an outstanding organization it was. “I think it is an amazing place and it should be something that’s cherished. We really need people to step up to be able to help families that need care and also help the hospital continue to provide the level of care that they do,” noted Lyons.
To donate directly to the Ann & Robert H. Lurie Children’s Hospital of Chicago, please visit https://www.luriechildrens.org/en/ways-to-help/.
In addition to the Ann & Robert H. Lurie Children’s Hospital of Chicago, Lyons has supported Home For Our Troops. The organization builds and donates custom-designed homes for veterans.
About John Lyons, Baird and Warner
John Lyons is a recipient of the Baird & Warner Founders’ Club award and the Baird & Warner Lincoln Park Best Dressed Agent award, which he earned in 2016. He works within a variety of Chicago neighborhoods, and typically services first-time buyers and sellers aiming to move out of state or into the suburbs. For more information, please call (773) 558-7133, or visit http://www.johnlyons.bairdwarner.com.
For media inquiries, please call the NALA at 805.650.6121, ext. 361. Reported by PRWeb 37 minutes ago.
↧
↧
RENNOVA HEALTH, INC. ANNOUNCES FURTHER CHANGE IN EFFECTIVE DATE OF REVERSE STOCK SPLIT DUE TO FEDERAL HOLIDAY
WEST PALM BEACH, Fla, Nov. 09, 2018 (GLOBE NEWSWIRE) -- *Rennova Health, Inc. (OTC: RNVA) (OTC: RNVAW), *today announced that the effective time of the reverse split announced yesterday of 5:00 pm, Eastern Time, on November 9, 2018, has been moved to 5:00 pm, Eastern Time, on November 12, 2018 (the “Effective Time”), at which point, the Company will effect a 1 for 500 reverse stock split of its outstanding common stock. The Company’s common stock will open for trading on Tuesday November 13, 2018, on a post-split basis. This change was made following a recommendation made by FINRA due to Monday November 12, being Veterans Day, a Federal holiday.As a result of the reverse stock split, every 500 shares of the Company’s common stock issued and outstanding on the Effective Time will be consolidated into one issued and outstanding share, except to the extent that the reverse stock split results in any of the Company’s stockholders owning a fractional share, which fractional share will be in that case paid in cash. In connection with the reverse stock split, there will be no change in the nominal par value per share of $0.0001.
Trading of the Company’s common stock will continue, on a split-adjusted basis, with the opening of the markets on Tuesday, November 13, 2018, under the existing trading symbol “RNVA” under a new CUSIP number. Based on the number of shares outstanding on November 9, 2018, the reverse stock split will reduce the number of shares of the Company’s common stock outstanding from approximately 7.6 billion pre-reverse split shares to approximately 15.3 million post-reverse split.
All outstanding preferred shares, stock options, warrants, and equity incentive plans immediately prior to the reverse stock split generally will be appropriately adjusted by dividing the number of shares of common stock into which the preferred shares, stock options, warrants and equity incentive plans are exercisable or convertible by 500 and multiplying the exercise or conversion price by 500, as a result of the reverse stock split.
The Company has retained its transfer agent, Computershare, Inc., to act as its exchange agent for the reverse stock split. Computershare will provide stockholders of record as of the Effective Time a letter of transmittal providing instructions for the exchange of their stock certificates. Stockholders owning shares via a broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split, subject to brokers’ particular processes, and will not be required to take any action in connection with the reverse stock split.
The reverse stock split was approved by the directors of the Company, pursuant to a resolution adopted by written consent of the holders of the majority of the total voting power of the Company’s securities on August 22, 2018.
*About Rennova Health, Inc. *
Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com.
*Forward-Looking Statements *
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect,""estimate,""project,""budget,""forecast,""anticipate,""intend,""plan,""may,""will,""could,""should,""believes,""predicts,""potential,""continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company's most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
*Contacts: *
Rennova Health
Sebastien Sainsbury
561-666-9818
ssainsbury@rennovahealth.com Reported by GlobeNewswire 13 hours ago.
Trading of the Company’s common stock will continue, on a split-adjusted basis, with the opening of the markets on Tuesday, November 13, 2018, under the existing trading symbol “RNVA” under a new CUSIP number. Based on the number of shares outstanding on November 9, 2018, the reverse stock split will reduce the number of shares of the Company’s common stock outstanding from approximately 7.6 billion pre-reverse split shares to approximately 15.3 million post-reverse split.
All outstanding preferred shares, stock options, warrants, and equity incentive plans immediately prior to the reverse stock split generally will be appropriately adjusted by dividing the number of shares of common stock into which the preferred shares, stock options, warrants and equity incentive plans are exercisable or convertible by 500 and multiplying the exercise or conversion price by 500, as a result of the reverse stock split.
The Company has retained its transfer agent, Computershare, Inc., to act as its exchange agent for the reverse stock split. Computershare will provide stockholders of record as of the Effective Time a letter of transmittal providing instructions for the exchange of their stock certificates. Stockholders owning shares via a broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split, subject to brokers’ particular processes, and will not be required to take any action in connection with the reverse stock split.
The reverse stock split was approved by the directors of the Company, pursuant to a resolution adopted by written consent of the holders of the majority of the total voting power of the Company’s securities on August 22, 2018.
*About Rennova Health, Inc. *
Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com.
*Forward-Looking Statements *
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect,""estimate,""project,""budget,""forecast,""anticipate,""intend,""plan,""may,""will,""could,""should,""believes,""predicts,""potential,""continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company's most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
*Contacts: *
Rennova Health
Sebastien Sainsbury
561-666-9818
ssainsbury@rennovahealth.com Reported by GlobeNewswire 13 hours ago.
↧
British veterans in their 90s receive France's highest military honour for their role in WWII
Four British soldiers and a Bletchley Park code breaker have received France's highest military honour for their role in liberating the country during the Second World War.
Reported by MailOnline 11 hours ago.
↧
What Else for November 9, 2018
Oh hey there, it’s Kathleen, the youngest member of the LG team. Have I mentioned that yet today? It’s a travel day for Lainey so you’ve got me for What Else. Quick programming note: We’re dark on Monday for Remembrance Day in Canada and Veterans Day the US. We’ll be back to regular gossip schedule ...
Reported by Lainey Gossip 13 hours ago.
↧
